19-5893110-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001193375.3(NDUFA11):c.494C>T(p.Ala165Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,535,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001193375.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFA11 | NM_001193375.3 | c.494C>T | p.Ala165Val | missense_variant | 4/4 | NP_001180304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000267740 | ENST00000586349.5 | c.382+3343C>T | intron_variant | 2 | ENSP00000466639.1 | |||||
NDUFA11 | ENST00000418389.6 | c.494C>T | p.Ala165Val | missense_variant | 4/4 | 2 | ENSP00000389160.1 | |||
ENSG00000267740 | ENST00000585661.1 | c.307+3343C>T | intron_variant | 2 | ENSP00000467210.1 | |||||
ENSG00000267740 | ENST00000592091.5 | n.313+3343C>T | intron_variant | 2 | ENSP00000465499.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000732 AC: 10AN: 136598Hom.: 0 AF XY: 0.0000808 AC XY: 6AN XY: 74294
GnomAD4 exome AF: 0.000147 AC: 204AN: 1383852Hom.: 0 Cov.: 32 AF XY: 0.000158 AC XY: 108AN XY: 682864
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.494C>T (p.A165V) alteration is located in exon 4 (coding exon 4) of the NDUFA11 gene. This alteration results from a C to T substitution at nucleotide position 494, causing the alanine (A) at amino acid position 165 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Mitochondrial complex 1 deficiency, nuclear type 14 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Aug 28, 2019 | A heterozygous missense variant was identified, NM_001193375.1(NDUFA11):c.494C>T in exon 4 of 4 of the NDUFA11 gene (NB: This variant is non-coding in the predominant alternative transcript, NM_175614.4). This substitution is predicted to create a minor amino acid change from alanine to valine at position 165 of the protein, NP_001180304.1(NDUFA11):p.(Ala165Val). The alanine at this position has low conservation (100 vertebrates, UCSC), and is not situated in a known functional domain. In silico software predictions of the pathogenicity of this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.0083% (14 heterozygotes, 0 homozygotes). The variant has been previously reported in a clinical testing setting. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS) with LOW CLINICAL RELEVANCE. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at